A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors

201466 citationsJournal Article

Authors

The results obtained in this study support further evaluation of PF-04449913 in patients with advanced solid tumors.

Good health and well-being

Published in: Clinical Cancer Research

Volume 21, Issue 5, pp. 1044-1051

Field-Weighted Citation Impact: 2.79